ADVERTISEMENT
Shanu Modi, MD, Discusses the DESTINY-Breast01 Trial
12/15/2019
Dr Modi discusses the basis, clinical significance, and findings of the DESTINY-Breast01 trial of DS-8201a therapy for HER2-low breast cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement